Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis B virus (HBV) RNA transcripts are a set of viral RNAs produced during the replication cycle of HBV. Major transcripts include pregenomic RNA (pgRNA), precore mRNA (pcRNA), 2.4 kb mRNA, 2.1 kb mRNAs, and 0.7 kb mRNA. These transcripts are crucial for viral protein production, genome replication, and assembly. Targeting HBV RNA transcripts is a central antiviral strategy, with siRNAs being explored to silence specific transcripts. The abundance and reduction patterns of different transcript types can indicate the source of viral antigens during chronic infection, making them critical targets for molecular diagnostics and therapeutic intervention.
siRNAs silence specific HBV RNA transcripts derived from cccDNA or integrated sequences.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B Virus RNA Transcripts (HBV RNA).